The mTOR Pathway Disease Node is holding a 1-day symposium, jointly with the MRC Centre for Neurodevelopmental Disorders (NDDs), on rare NDDs at Bush house, London on 23rd April 2024:
“Tackling challenges in rare neurodevelopmental disorders: an integrated perspective”
The symposium aims to spotlight the major challenges and latest developments in rare neurodevelopmental disorder (NDD) research from the viewpoint of people with lived experience, clinical researchers, basic scientists, industry and the NHS.
Objectives:
· Understand the overall landscape of rare NDDs.
· Describe gaps in evidence and major challenges in translational research.
· Learn how basic science can address key obstacles in early translation.
· Appreciate the complexities of evidence generation for new drug development and approvals.
Organising committee:
· Professor Joseph Bateman, Basic and Clinical Neuroscience, KCL, NIHR/MRC mTOR Pathway Diseases node lead
· Professor Deb Pal, Basic and Clinical Neuroscience, KCL, MRC CNDD, NIHR/MRC mTOR Pathway Diseases co-I
· Professor Juan Burrone, Department of Developmental Neurobiology, KCL, MRC CNDD
· Dr Setsuko Sahara, Department of Developmental Neurobiology, KCL, MRC CNDD
Confirmed speakers:
1) Albert Basson, University of Exeter Medical School
2) Anna Jansen, University of Antwerp
3) Baptiste Libe-Philippot, VIB-KU Leuven Center for Brain & Disease Research
4) David Collier, King’s College London
5) Gabriele Lignani, University College London
6) Lettie Rawlins, University of Exeter Medical School
7) Sarah Goy, rare NDD patient and visual artist
8) Sila Ultanir, the Francis Crick Institute
9) Stefanie Dedeurwaerdere, UCB Global Pipeline Development Strategy
10) Stéphanie Baulac, Paris Brain Institute
11) Victoria Lund, MRC, UKRI
12) Amy McTague, Great Ormond Street Hospital
